Search Results

Filter
  • 1-10 of  33,014 results for ""Botulinum Toxins, Type A""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Letter to the editor for the article "Is bulbospongiosus muscle botox injection safe and effective in treating lifelong premature ejaculation? Randomized controlled study".

  • Authors : Wang Y; Department of Gastrointestinal Surgery, Peking University First Hospital, No. 8 Xishku Street, Xicheng District, Beijing, China.; Pan Y

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Premature Ejaculation*/Premature Ejaculation*/Premature Ejaculation*/drug therapy

  • Source: World journal of urology [World J Urol] 2024 May 10; Vol. 42 (1), pp. 313. Date of Electronic Publication: 2024 May 10.Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder.

  • Authors : Gotoh D; Department of Urology, Nara Medical University, Kashihara, Japan.; Torimoto K

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/adverse effects

  • Source: In vivo (Athens, Greece) [In Vivo] 2024 May-Jun; Vol. 38 (3), pp. 1332-1337.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Nerve Block Guided by Anatomic Landmarks Only Reduces Pain in Botulinum Toxin Type A Treatment for Glabellar and Forehead Wrinkles.

  • Authors : Chen C; From the The Burns and Plastic Surgery Department of the Hainan Hospital of the People's Liberation Army General Hospital, Honglong Road, Sanya City, Hainan Province, China.; Zhou L

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Forehead*/Forehead*/Forehead*/innervation

  • Source: Annals of plastic surgery [Ann Plast Surg] 2024 May 01; Vol. 92 (5), pp. 508-513.Publisher: Little, Brown And Company Country of Publication: United States NLM ID: 7805336 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Addressing limitations of single GON blockade treatment and repetitive intervention with GON block or onabotulinum toxin A in chronic migraine- part 2 of three men in a boat study.

  • Authors : Karaoğlan M; Ordu State Hospital, Department of Algology, Ordu, Turkey. Electronic address: .

Subjects: Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage

  • Source: Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2024 May; Vol. 240, pp. 108242. Date of Electronic Publication: 2024 Mar 12.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of botulinum toxin for rosacea with positive impact on quality of life and self-esteem.

  • Authors : Takahashi KH; Dermatology Outpatient Clinic, Department of Clinics, Faculty of Medical and Health Sciences at Pontifical Catholic University of São Paulo, São Paulo, Brazil.; Utiyama TO

Subjects: Rosacea*/Rosacea*/Rosacea*/drug therapy ; Rosacea*/Rosacea*/Rosacea*/psychology ; Quality of Life*

  • Source: International journal of dermatology [Int J Dermatol] 2024 May; Vol. 63 (5), pp. 590-596. Date of Electronic Publication: 2024 Jan 21.Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.

  • Authors : Lee JS; From the Department of Dermatology, Konkuk University School of Medicine.; Son HS

Subjects: Masseter Muscle*/Masseter Muscle*/Masseter Muscle*/*abnormalities; Hypertrophy*/Hypertrophy*/Hypertrophy*/drug therapy ; Masseter Muscle*/Masseter Muscle*/Masseter Muscle*/pathology Masticatory Muscles, Hypertrophy of

  • Source: Plastic and reconstructive surgery [Plast Reconstr Surg] 2024 May 01; Vol. 153 (5), pp. 910e-918e. Date of Electronic Publication: 2023 Jun 19.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 1306050 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Analgesia Using Transcutaneous Electric Nerve Stimulation in Office Bladder Chemodenervation, a Randomized Controlled Trial.

  • Authors : Hernandez-Aranda D; From the Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, University of Rochester School of Medicine and Dentistry.; Panza J

Subjects: Transcutaneous Electric Nerve Stimulation*/Transcutaneous Electric Nerve Stimulation*/Transcutaneous Electric Nerve Stimulation*/methods ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use

  • Source: Urogynecology (Philadelphia, Pa.) [Urogynecology (Phila)] 2024 May 01; Vol. 30 (5), pp. 498-504. Date of Electronic Publication: 2023 Nov 06.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9918452588006676 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.

  • Authors : Li K; Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.; Tan K

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Temporomandibular Joint Disorders*/Temporomandibular Joint Disorders*/Temporomandibular Joint Disorders*/drug therapy; Humans

  • Source: Journal of oral rehabilitation [J Oral Rehabil] 2024 May; Vol. 51 (5), pp. 886-897. Date of Electronic Publication: 2023 Dec 27.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0433604 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Botulinum Toxin Injections for Psychiatric Disorders: A Systematic Review of the Clinical Trial Landscape.

  • Authors : Demchenko I; Interventional Psychiatry Program, St. Michael's Hospital-Unity Health Toronto, 193 Yonge Street, Toronto, ON M5B 1M4, Canada.; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.

Subjects: Mental Disorders*/Mental Disorders*/Mental Disorders*/drug therapy ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage

  • Source: Toxins [Toxins (Basel)] 2024 Apr 15; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

Record details

×
Academic Journal

Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study.

  • Authors : Montisano DA; Neuroalgology Unit and Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133 Milan, Italy.; Giossi R

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/immunology ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy

  • Source: Toxins [Toxins (Basel)] 2024 Apr 07; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

Record details

×
  • 1-10 of  33,014 results for ""Botulinum Toxins, Type A""